as on January 17, 2026 at 2:28 am IST
Day's Low
Day's High
4.50%
Downside
1.80%
Upside
52 Week's Low
52 Week's High
7.21%
Downside
645.05%
Upside
Check Inmed Pharmaceuticals Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$3.0M
EPS (TTM)
0Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.00%
PE Ratio (TTM)
-0.51
Industry PE ratio
0PEG Ratio
0EBITDA
-7.7M
Revenue (TTM)
4.8M
Profit Margin
-171.13%
Return On Equity TTM
-82.17%
Track how Inmed Pharmaceuticals Inc P/E has moved over time to understand its valuation trends.
Inmed Pharmaceuticals Inc in the last 5 years
Lowest (-105.76x)
March 31, 2021
Industry (0.00x)
January 17, 2026
Today (-0.51x)
January 17, 2026
Highest (-0.33x)
September 30, 2025
Today’s Price to Earnings Ratio: -0.51x
Compare market cap, revenue, PE, and other key metrics of Inmed Pharmaceuticals Inc with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
|---|---|---|---|---|---|
| $3.0M | -99.95% | -0.51 | -171.13% |
The Inmed Pharmaceuticals Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Inmed Pharmaceuticals Inc investment value today
Current value as on today
₹27,310
Returns
Returns from Inmed Pharmaceuticals Inc Stock
Dollar Returns*
₹4,886 (+4.89%)
Based on 8 analysts
0.00%
Buy
37.50%
Hold
62.50%
Sell
Based on 8 analysts, 62.5% of analysts recommend a 'SELL' rating for Inmed Pharmaceuticals Inc. Average target price of $20
Get share price movements and forecasts by analysts on Inmed Pharmaceuticals Inc.
What analysts predicted
94.45%UPSIDE
Target Price
$20
Current Price
$1.11
Analyzed by
8 Analysts
Target
$20.00
Inmed Pharmaceuticals Inc target price $20, a slight upside of 94.45% compared to current price of $1.11. According to 8 analysts rating.
Search interest for Inmed Pharmaceuticals Inc Stock has decreased by -20% in the last 30 days, reflecting a downward trend in search activity.
Time period: to
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Retail Holding Up
![]()
Retail Investor have increased holdings from 21.76% to 26.20% in Sep 2025 quarter
Profit Spike
![]()
Netprofit is up for the last 2 quarters, -2.43M → -1.72M (in $), with an average increase of 41.1% per quarter
Against Peers
![]()
In the last 1 year, Regencell Bioscience Holdings Ltd has given 21532.5% return, outperforming this stock by 21610.3%
Against Peers
![]()
In the last 3 years, Regencell Bioscience Holdings Ltd has given 3596.3% return, outperforming this stock by 3693.6%
FII Holding Down
![]()
Foreign Institutions have decreased holdings from 7.99% to 5.26% in Sep 2025 quarter
Promoter Holding Down
![]()
Promoters have decreased holdings from 70.26% to 68.54% in Sep 2025 quarter
Revenue Fall
![]()
Revenue is down for the last 2 quarters, 1.77M → 1.12M (in $), with an average decrease of 37.0% per quarter
Price Dip
![]()
In the last 7 days, INM stock has moved down by -14.7%
Price Dip
![]()
In the last 7 days, INM stock has moved down by -7.1%
| Organisation | Inmed Pharmaceuticals Inc |
| Headquarters | 885 West Georgia Street, Vancouver, BC, Canada, V6C 3E8 |
| Industry | Health Technology |
| CEO | Mr. Eric A. Adams B.S. Chem., M.I.B. |
| E-voting on shares | Click here to vote |
Name | Title |
|---|---|
Dr. Sazzad Hossain M.Sc., Ph.D. | Co-Founder |
Colin Clancy | Senior Director of Investor Relations |
Mr. Jerry P. Griffin | Vice President of Sales & Marketing |
Dr. Shane A. Johnson Ph.D. | Senior VP & GM of BayMedica |
Mr. Eric A. Adams B.S. Chem., M.I.B. | President, CEO & Director |
Ms. N. Netta Jagpal | CFO & Corporate Secretary |
Mr. Michael Woudenberg P.Eng. | Chief Operating Officer |
Dr. Eric Chih-Hsien Hsu Ph.D. | Senior Vice President of Preclinical Research & Development |
Inmed Pharmaceuticals Inc share price today is $1.11 as on at the close of the market. Inmed Pharmaceuticals Inc share today touched a day high of $1.13 and a low of $1.06.
Inmed Pharmaceuticals Inc share touched a 52 week high of $8.27 on and a 52 week low of $1.03 on . Inmed Pharmaceuticals Inc stock price today i.e. is closed at $1.11,which is 86.58% down from its 52 week high and 7.77% up from its 52 week low.
Inmed Pharmaceuticals Inc market capitalisation is $0.00T as on .
Indian investors can start investing in Inmed Pharmaceuticals Inc (INM) shares with as little as ₹90.81 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹908.10 in Inmed Pharmaceuticals Inc stock (as per the Rupee-Dollar exchange rate as on ).
Based on Inmed Pharmaceuticals Inc share’s latest price of $1.11 as on January 17, 2026 at 2:28 am IST, you will get 9.0090 shares of Inmed Pharmaceuticals Inc. Learn more about
fractional shares .
Inmed Pharmaceuticals Inc stock has given -99.95% share price returns and 23.36% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?